4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
9.25
+0.15 (1.65%)
At close: Feb 11, 2026, 4:00 PM EST
9.39
+0.14 (1.51%)
Pre-market: Feb 12, 2026, 6:41 AM EST
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $471.82 million as of February 12, 2026. Its market cap has increased by 119.49% in one year.
Market Cap
471.82M
Enterprise Value
121.86M
1-Year Change
119.49%
Ranking
Category
Stock Price
$9.25
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $471.82M, a decrease of -18.70%. That is a compound annual growth rate of -3.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 471.82M | 10.11% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 487.54M |
| Prothena Corporation | 482.59M |
| Tectonic Therapeutic | 464.35M |
| Lyell Immunopharma | 461.42M |
| Kyverna Therapeutics | 456.46M |
| Ocugen | 452.49M |
| Vanda Pharmaceuticals | 441.45M |
| LENZ Therapeutics | 439.15M |